5.23
0.19%
0.01
Dopo l'orario di chiusura:
5.23
Precedente Chiudi:
$5.22
Aprire:
$5.24
Volume 24 ore:
5,482
Relative Volume:
0.24
Capitalizzazione di mercato:
$192.43M
Reddito:
$7.80M
Utile/perdita netta:
$-69.02M
Rapporto P/E:
-2.4424
EPS:
-2.1413
Flusso di cassa netto:
$-66.61M
1 W Prestazione:
-1.84%
1M Prestazione:
+4.81%
6M Prestazione:
-17.96%
1 anno Prestazione:
+12.47%
Molecular Partners Ag Adr Stock (MOLN) Company Profile
Nome
Molecular Partners Ag Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MOLN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
MOLN
Molecular Partners Ag Adr
|
5.23 | 192.43M | 7.80M | -69.02M | -66.61M | -2.1413 |
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-08-30 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-08-29 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2022-05-25 | Aggiornamento | Credit Suisse | Underperform → Neutral |
2022-04-27 | Downgrade | Credit Suisse | Neutral → Underperform |
2021-07-13 | Iniziato | Cowen | Outperform |
2021-07-12 | Ripresa | SVB Leerink | Outperform |
Mostra tutto
Molecular Partners Ag Adr Borsa (MOLN) Ultime notizie
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Here's Why Seagate (STX) is a Strong Momentum Stock - Yahoo Finance
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Molecular Partners expands 212Pb co-development agreement with Orano Med - TipRanks
Molecular Partners shares gain on Leerink's outperform rating - Investing.com
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Molecular Partners Unveils Promising Cancer Therapy - TipRanks
Molecular Partners Shares Rise on Positive Trial Data for MP0317 - MarketWatch
Molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero (NASDAQ:MOLN) - Seeking Alpha
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com UK
US stock market gainers for the last week of April 2022 - Nairametrics
Market Data Center - Barron's
Molecular Partners Ag Adr Azioni (MOLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):